Mesenchymal Stem Cell Secretome: A Potential Therapeutic Approach for Lupus
A meta-analysis of nine randomized controlled trials (RCTs) highlights the potential of mesenchymal stem cell secretome (MSCS) in managing systemic lupus erythematosus (SLE). Findings suggest that MSCS therapy may reduce disease activity and improve immune function, with no serious effects reported.
